Sign in / Join Now
ETFs & Funds
As far as
, they have a huge problem with Jakafi. For details, look at youtube video by Dr. Pardanani, who is @ Mayo.
Jakafi is a terrible drug for MF and should not have been approved by the FDA. This makes other indications for Jakafi very questionable.
Add a reply...
Latest StockTalks »
people get INCY breaking news and analysis by email alert.
Get email alerts on INCY »
Get latest price
From other sites
Zacks.com featured highlights: Incyte, LegacyTexas Financial Group, Exelixis, Bayerische Motoren Werke Aktiengesellschaft and EQT Midstream Partners
at Zacks.com (Wed, 9:30AM)
Incyte To Report Third Quarter Financial Results
at TheStreet (Oct 14, 2016)
The Street Is Seeing Higher Probability Of Success For Incyte's Melanoma Treatment
at Benzinga (Oct 10, 2016)
Can the Rally in Incyte (INCY) Shares Continue?
at Zacks.com (Oct 10, 2016)
Additional Phase 1 Data From ECHO-202 Reinforce Durability Of Response In Patients With Treatment-naive Advanced Or Metastatic Melanoma Treated With Epacadostat In Combination With Keytruda® (pembrolizumab)
at TheStreet (Oct 7, 2016)